2m 2m 2m 2m 2m 2m 2m
ATYR PHARMA (ATYR)
NASDAQ
$0.50-$0.04 (-6.91%)
Price as of Jun 23, 2026 7:40 PM EDT- $46.1MMarket Cap
- -89.89%1-Year Change
- BiotechnologyIndustry
ATYR PHARMA (ATYR)
$0.50-$0.04 (-6.91%)
ATYR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | +$0.07 (+14.23%) | ||
Open | $0.46 | ||
High | $0.56 | ||
Low | $0.46 | ||
Previous Close | $0.47 | ||
Volume | 2,898,065 | ||
30-Day Average Volume | 2,488,592 | ||
1-Week Change | 19.94% | ||
1-Month Change | 9.61% | ||
1-Year Change | -89.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 98.1M | ||
Total Assets | $79.7M | ||
Market Cap | $46.1M | ||
Enterprise Value | $36.1M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$10.8M | ||
Free Cash Flow | -$12.7M | ||
EBIT | -$10.8M | ||
EBITDA | -$10.6M | ||
Net Working Capital | $55.9M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue